Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant-Reference-Cited by-同舟云学术

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Published:2013-11 Issue:11 Volume:21 Page:2113-2121
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Gerdemann Ulrike,Katari Usha L,Papadopoulou Anastasia,Keirnan Jacqueline M,Craddock John A,Liu Hao,Martinez Caridad A,Kennedy-Nasser Alana,Leung Kathryn S,Gottschalk Stephen M,Krance Robert A,Brenner Malcolm K,Rooney Cliona M,Heslop Helen E,Leen Ann M

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference42 articles.

1. Prospective, comprehensive and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation;Schonberger;Biol.Blood Marrow Transplant,2010

2. Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience;Verdeguer;Bone Marrow Transplant,2011

3. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals;Leen;Nat Med,2006

4. Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant;Sili;Cytotherapy,2012

5. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy;Leen;J Virol,2008

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation;Frontiers in Immunology;2024-01-11

2. Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay;Frontiers in Immunology;2023-12-22

3. A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications;Molecular Therapy - Methods & Clinical Development;2023-09

4. T-lymphocyte depleted transplants for inborn errors of immunity;Expert Review of Clinical Immunology;2023-08-09

5. Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study);2023-06-02